9.24  -0.04 (-0.43%)		02-14 16:00
Open: 10.5 High: 10.5 Volume: 7,294		Pre. Close: 9.28 Low: 9.24 Market Cap: 72(M)

Short term
Mid term
Targets	6-month :	15.42	1-year :	18.45
Resists	First :	13.2	Second :	15.8
Pivot price	11.26
Supports	First :	9	Second :	7.48
MAs	MA(5) :	10.21	MA(20) :	11.41
	MA(100) :	11.61	MA(250) :	11.39
MACD	MACD :	-0.5	Signal :	-0.1
%K %D	K(14,3) :	3.5	D(3) :	14.1
RSI	RSI(14): 38.9
52-week	High :	15.8	Low :	9

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PWUP ] has closed above bottom band by 12.9%. Bollinger Bands are 390.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	9.27 - 9.32	9.32 - 9.36
Low:	9.08 - 9.15	9.15 - 9.21
Close:	9.13 - 9.24	9.24 - 9.33

PowerUp Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify and acquire a business within the interactive media, digital media, sports, entertainment, and/or leisure areas. The company was incorporated in 2021 and is based in New York, New York.

Mon, 19 May 2025
(PWUP) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Thu, 20 Feb 2025
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq - Yahoo Finance

Wed, 19 Feb 2025
PowerUp Acquisition Completes Combination; Aspire Biopharma Gains Nasdaq Listing - marketscreener.com

Wed, 19 Feb 2025
This New Nasdaq Biotech Could Revolutionize Emergency Cardiac Care - Here's Why - Stock Titan

Mon, 10 Feb 2025
PowerUp Acquisition Corp. Approves Merger with Aspire Biopharma - Investing.com

Thu, 10 Oct 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBZ, PWUP, ESGR on Behalf of Shareholders - GlobeNewswire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Shell Companies
Shares Out	8 (M)
Shares Float	0 (M)
Held by Insiders	15.4 (%)
Held by Institutions	1 (%)
Shares Short	2 (K)
Shares Short P.Month	2 (K)

EPS	-0.41
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.84
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-9.7 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	-3 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-23.1
PEG Ratio	0
Price to Book value	-11
Price to Sales	0
Price to Cash Flow	-24.1

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.